David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$354M |
| 2 |
Wells Fargo
WFC
|
+$274M |
| 3 |
IBM
IBM
|
+$266M |
| 4 |
Qualcomm
QCOM
|
+$257M |
| 5 |
Mondelez International
MDLZ
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$356M |
| 2 |
PayPal
PYPL
|
+$290M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$261M |
| 4 |
NVIDIA
NVDA
|
+$248M |
| 5 |
AABA
Altaba Inc
AABA
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.31% |
| 2 | Healthcare | 10.66% |
| 3 | Consumer Discretionary | 10.29% |
| 4 | Communication Services | 8.78% |
| 5 | Financials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PPLI
951
PUT
People Inc
PPLI
$2.94B
| $9.57M | 0.01% |
455,466
+257,948
| +131% | +$5.01M |
|
|
PMC
952
DELISTED
PharMerica Corporation
PMC
| $9.57M | 0.01% |
326,593
-46,585
| -12% | -$1.3M |
|
|
XOXO
953
DELISTED
Xo Group Inc
XOXO
| $9.56M | 0.01% |
486,226
-2,288
| -0.5% | -$42.1K |
|
954
NiSource
NI
$19.6B
| $9.52M | 0.01% |
371,905
-158,181
| -30% | -$4.16M |
|
955
Ford
F
$55.7B
| $9.48M | 0.01% |
791,838
-303,851
| -28% | -$3.43M |
|
|
LMNX
956
DELISTED
Luminex Corp
LMNX
| $9.47M | 0.01% |
465,952
+38,139
| +9% | +$760K |
|
957
World Acceptance Corp
WRLD
$905M
| $9.46M | 0.01% |
114,085
+7,867
| +7% | +$607K |
|
|
ABMD
958
DELISTED
Abiomed Inc
ABMD
| $9.43M | 0.01% |
55,943
-141,382
| -72% | -$21.4M |
|
959
Smith & Nephew
SNN
$12.2B
| $9.4M | 0.01% |
258,371
-22,975
| -8% | -$817K |
|
960
Avnet
AVT
$7.1B
| $9.4M | 0.01% |
239,179
-285,992
| -54% | -$11M |
|
|
FOE
961
DELISTED
Ferro Corporation
FOE
| $9.39M | 0.01% |
421,118
-101,638
| -19% | -$1.98M |
|
962
CALL
IPG Photonics
IPGP
$3.03B
| $9.38M | 0.01% |
50,700
+18,400
| +57% | +$3.06M |
|
|
HRG
963
DELISTED
HRG Group, Inc.
HRG
| $9.38M | 0.01% |
+600,902
| New | +$9.71M |
|
|
DNR
964
DELISTED
Denbury Resources, Inc.
DNR
| $9.38M | 0.01% |
6,998,841
-206,574
| -3% | -$269K |
|
965
8x8 Inc
EGHT
$277M
| $9.37M | 0.01% |
694,238
+198,698
| +40% | +$2.71M |
|
966
Herc Holdings
HRI
$5.2B
| $9.37M | 0.01% |
190,760
-18,295
| -9% | -$793K |
|
967
PNC Financial Services
PNC
$97.4B
| $9.37M | 0.01% |
69,501
-459,070
| -87% | -$58.9M |
|
|
HIFR
968
DELISTED
InfraREIT, Inc.
HIFR
| $9.36M | 0.01% |
418,478
+12,497
| +3% | +$268K |
|
969
Magnachip Semiconductor
MX
$119M
| $9.36M | 0.01% |
824,269
-203,622
| -20% | -$2.25M |
|
|
AZPN
970
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $9.28M | 0.01% |
147,749
-14,205
| -9% | -$892K |
|
971
CBIZ
CBZ
$2.96B
| $9.27M | 0.01% |
570,366
+21,577
| +4% | +$325K |
|
|
AGR
972
DELISTED
Avangrid, Inc.
AGR
| $9.2M | 0.01% |
193,898
+56,157
| +41% | +$2.61M |
|
973
CALL
Broadcom
AVGO
$1.7T
| $9.19M | 0.01% |
379,000
-564,000
| -60% | -$13.9M |
|
|
RPAI
974
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
| $9.15M | 0.01% |
697,223
-1,060,471
| -60% | -$13.9M |
|
975
Viatris
VTRS
$19.1B
| $9.15M | 0.01% |
291,631
-14,234
| -5% | -$483K |
|
Similar funds
David Shaw's Q3 2017 Portfolio in Review
As of Q3 2017, David Shaw held 3,794 positions worth $65.1B, up 7.7% from $60.5B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
David Shaw's Q3 2017 filing shows 469 new, 1,367 increased, 1,237 reduced and 370 closed positions. Its largest new stake was Baker Hughes: 3,076,914 shares worth $113M. The largest sale was Gilead Sciences, an estimated $356M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- David Shaw's largest Q3 2017 buy was Baker Hughes: 3,076,914 shares worth $113M.
- David Shaw added most to Comcast in Q3 2017, an estimated $354M increase.
- David Shaw's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $356M.
- David Shaw fully exited Mobileye N.V. in Q3 2017, selling an estimated $72.4M.
- David Shaw's ten largest holdings make up 9.6% of its $65.1B portfolio in Q3 2017.
- David Shaw opened 469 new positions and closed 370 in Q3 2017.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $65.1B.
Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.